We are live on
!
Find out more
Nautilus Biotechnolgy
NAUT
NAUT
81 hedge funds and large institutions have $211M invested in Nautilus Biotechnolgy in 2026 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 16 increasing their positions, 16 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
178% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 9
85% more capital invested
Capital invested by funds: $114M → $211M (+$96.9M)
19% more funds holding
Funds holding: 68 → 81 (+13)
0% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 16
3.31% less ownership
Funds ownership: 46.25% → 42.94% (-3.3%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
81
Holders Change
+13
Holders Change %
+19.12%
% of All Funds
1%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.02%
New
25
Increased
16
Reduced
16
Closed
9
Calls
$261K
Puts
–
Net Calls
+$261K
Net Calls Change
+$257K
Top Buyers
| 1 |
CA
Clearstead Advisors
Cleveland,
Ohio
|
+$5.72M |
| 2 |
Millennium Management
New York
|
+$623K |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$498K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$318K |
| 5 |
CAM
Crown Advisors Management
Larkspur,
California
|
+$246K |
